Risa Ozaki

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism

William L. Lowe, Denise Scholtens, Alan Kuang et al. · Diabetes Care · 2019 · 548 citations · Full text

In Utero Exposure to Maternal Hyperglycemia Increases Childhood Cardiometabolic Risk in Offspring

Wing Hung Tam, Risa Ozaki, Albert Martin Li et al. · Diabetes Care · 2017 · 356 citations · Full text

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

Roseanne O. Yeung, Yuying Zhang, Andrea O. Y. Luk et al. · The Lancet Diabetes & Endocrinology · 2014 · 291 citations

Obesity, Metabolic Syndrome, Diabetes Management +10